Alumis has concluded enrolment in its pivotal Phase III ONWARD programme of ESK-001 for treating plaque psoriasis.

Centrally stored body fat is more strongly linked to an increased risk of psoriasis than overall body fat, a study has ...

Misinterpretation of MRI findings by clinicians focused on earlier intervention is leading to increased rates of ...

Transform your beauty routine with fish oil Learn how omega-3s can hydrate skin fight acne reduce wrinkles and promote ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Menthol is extracted from mint plants, creating a cooling sensation and providing temporary relief through counter-irritation ...

We delve into the world of mood-responsive skincare. Here is everything you need to know, plus the formulas to try.

MS affects millions globally and remains a chronic, often disabling disease surrounded by stigma and misunderstanding.

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing ...

Dr Conor Kerley–who has the disease himself– says there are several theories as to why the small island has such a ...

A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited ...